Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.87M Buy
31,074
+23,200
+295% +$5.68M 0.41% 77
2025
Q4
$2M Sell
7,874
-4,322
-35% -$1.09M 0.13% 249
2025
Q3
$3.02M Buy
+12,196
New +$2.92M 0.19% 184
2024
Q2
Sell
-2,200
Closed -$495K 743
2024
Q1
$495K Sell
2,200
-501
-19% -$113K 0.05% 455
2023
Q4
$594K Buy
2,701
+1
+0% +$211 0.07% 376
2023
Q3
$592K Buy
+2,700
New +$611K 0.07% 389
2022
Q3
Sell
-3,623
Closed -$747K 1068
2022
Q2
$747K Buy
+3,623
New +$817K 0.07% 481
2015
Q3
Sell
-29,912
Closed -$1.93M 1547
2015
Q2
$1.93M Buy
+29,912
New +$2.02M 0.05% 444
2014
Q3
Sell
-38,665
Closed -$2.07M 1574
2014
Q2
$2.07M Buy
+38,665
New +$1.99M 0.06% 425
2013
Q3
Sell
-67,784
Closed -$2.91M 1702
2013
Q2
$2.91M Buy
+67,784
New +$2.92M 0.07% 381

Other funds holding STE

PDT Partners's STE Position: Q1 2026 in Review

PDT Partners increased its Steris (STE) stake by 295% in Q1 2026, buying an estimated $5.68M and bringing the position to 31,074 shares worth $6.87M. The position accounts for 0.41% of the portfolio, ranked #77.

PDT Partners first reported a position in STE in Q2 2013 and has held it in 10 quarters since. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • PDT Partners held 31,074 shares of Steris worth $6.87M as of Q1 2026.
  • PDT Partners bought 23,200 Steris shares in Q1 2026, an estimated $5.68M.
  • Steris made up 0.41% of PDT Partners's portfolio in Q1 2026, its #77 holding.
  • PDT Partners first reported a position in Steris in Q2 2013 and has held it in 10 quarters since.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.